德国法兰克福血液学/肿瘤学系和大学癌症研究中心的负责人，UCT科学工作组主任，德国癌症转化研究联盟和法兰克福癌症研究所的主要研究员

德国和欧洲白血病网络的董事会成员和欧洲成人白血病工作组的创始成员。

代表GMALL研究小组发表了许多关于ALL的评论文章和原创文章，并在各种国际会议上担任特邀发言人。

Blast研究第一作者，并作为主要研究者或参加倍利妥及奥伊加妥珠单抗多项全球临床研究，具有丰富的临床研究及管理经验。

25年来，Nicola Gökbuget一直担任德国成人ALL多中心研究组（GMALL）的协调员，参与医院超140多家。她建立了一个全国性的ALL注册中心和一个相关的生物库。同时她也担任成人ALL和相关疾病许多试验的协调研究员。

研究集中在成人ALL的临床研究，包括诊断、治疗、基于MRD的治疗、晚期反应、生活质量、复发/抗性疾病的管理和新药的评估。

Nicola Gökbuget is head of the Study Centre of the Department of Haematology/Oncology and the University Cancer Centre (UCT) in Frankfurt, Germany. She is among the UCT Scientific Task Force Directors, the Principal Investigators of the German Consortium for Translational Cancer Research and the Frankfurt Cancer Institute.

Since more than 25 years she serves as Coordinator of the German Multicentre Study Group for Adult ALL (GMALL) with more than 140 participating hospitals. She has also founded and established a national ALL registry with an associated biobank. She is coordinating investigator of numerous trials in adult ALL and related diseases.

She is also board member of the German and European Leukaemia Net and founding member of the European Working Group for Adult ALL.

Her scientific interest focuses on clinical research in adult ALL including diagnosis, therapy, MRD based treatment, late effects, quality of life, management of relapsed/resistant disease and evaluation of new drugs.  

She has published numerous review articles and original articles on ALL on behalf of the GMALL study group and acted as invited speaker at various international meetings.